Literature DB >> 25303229

Combined effects of admission serum creatinine concentration with age and gender on the prognostic significance of subjects with acute ST-elevation myocardial infarction in China.

Zhao-Yang Li1, Zhao-Hong Chen2, Feng-Hui An2, Li-Hua Li2, Chang-Yan Guo1, Yan Gu1, Zhe Liu1, Tie-Bing Zhu1, Lian-Sheng Wang1, Chun-Jian Li1, Xiang-Qing Kong1, Wen-Zhu Ma1, Zhi-Jian Yang1, En-Zhi Jia1.   

Abstract

OBJECTIVE: to explore the impact of admission serum creatinine concentration on the in-hospital mortality and its interaction with age and gender in patients with acute ST-segment elevation myocardial infarction (STEMI) in China.
METHODS: 1424 acute STEMI patients were enrolled in the study. Anthropometric and laboratory measurements were collected from every patient. A Cox proportional hazards regression model was used to determine the relationships between the admission serum creatinine level (Cr level), age, sex and the in-hospital mortality. A crossover analysis and a stratified analysis were used to determine the combined impact of Cr levels with age and gender.
RESULTS: Female (HR 1.687, 95%CI 1.051 ∼ 2.708), elevated Cr level (HR 5.922, 95%CI 3.780 ∼ 9,279) and old age (1.692, 95%CI 1.402 ∼ 2.403) were associated with a high risk of death respectively. After adjusting for other confounders, the renal dysfunction was still independently associated with a higher risk of death (HR 2.48, 95% CI 1.32 ∼ 4.63), while female gender (HR 1.19, 95%CI 0.62 ∼ 2.29) and old age (HR 1.77, 95%CI 0.92 ∼ 3.37) was not. In addition, crossover analysis revealed synergistic effects between elevated Cr level and female gender (SI = 3.01, SIM = 2.10, AP = 0.55). Stratified analysis showed that the impact of renal dysfunction on in-hospital mortality was more pronounced in patients <60 years old (odds ratios 11.10, 95% CI 3.72 to 33.14) compared with patients 60 to 74 years old (odds ratios 5.18, 95% CI 2.48 ∼ 10.83) and patients ≥ 75 years old (odds ratios 3.99, 95% CI 1.89 to 8.42).
CONCLUSION: Serum Cr concentration on admission was a strong predictor for in-hospital mortality among Chinese acute STEMI patients especially in the young and the female.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25303229      PMCID: PMC4193830          DOI: 10.1371/journal.pone.0108986

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

ST-segment elevation myocardial infarction (STEMI) is a clinical syndrome defined by characteristic symptoms of myocardial ischemia in association with persistent electrocardiographic (ECG) ST elevation and subsequent release of biomarkers of myocardial necrosis [1]. Worldwide, coronary artery disease (CAD) is the single most frequent cause of death. Over seven million people every year die from CAD, accounting for 11.2% of all deaths [2]. Differing from USA, where the incidence of acute STEMI and rates of death attributable to CVD have declined [3], [4], cardiovascular diseases are rising as the primary cause of death and disability in China in decades [5], [6]. Patients with acute STEMI face higher in-hospital mortality for many factors. Renal dysfunction has been established as one of the most important predictors of in-hospital and long-term mortality in the acute STEMI patients [7], [8], Moreover, age as another significant predictor of adverse outcomes in this group, is related with the renal function [9]–[11], It has also been reported that females with acute myocardial infarction (AMI) have a higher risk of adverse events [12], [13]. Nevertheless, the relationship between the admission serum creatinine concentration (µmol/l) and the prognosis of acute STEMI patients has not been well characterized in China and few data are available concerning its interaction with age and gender. So, in our study, we aimed to examine the impact of admission serum creatinine concentration on the in-hospital mortality and its interaction with age and gender in patients with STEMI in China.

Materials and Methods

Study subjects

The patients admitted to First Affiliated Hospital of Nanjing Medical University, Nanjing (China) for acute STEMI from 1 January 2003 to 31 December 2010 (n = 1467) were enrolled in the study. Among these, 43 patients were excluded due to missing data of admission serum creatinine concentration, leaving 1424 patients (296 females), aging 26 to 98 years old for the analysis. All patients had no history of chronic renal diseases or tumors. The current guidelines for the ECG diagnosis of the STEMI require at least 1 mm (0.1 mV) of ST segment elevation in the limb leads, and at least 2 mm elevation in the precordial leads [14]. Coronary angiograms were scored according to Gensini's score. According to this system, a substantial reduction in lumen diameter is assigned a higher score than a distal lesion [15]. The primary outcome of the study was death from all causes during hospitalization. The study was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University, and written informed consent was obtained from each patient.

Blood sample and biochemistry measurements

The blood was withdrawn in the emergency room or coronary care unit within 12 hours since admission from every patient. All measurements were conducted at the clinical laboratory in the First Affiliated Hospital of Nanjing Medical University. The creatinine (Cr, µmol/L) levels were determined by enzymatic procedures on an automated auto-analyzer (AU 2700 Olympus, First Chemical Ltd, Tokyo, Japan).

Statistical analysis

Data were statistically analyzed using Statistics Package for Social Sciences (ver. 16.0; SPSS Incorporated, Chicago, IL, USA). Subjects were classified into 2 groups according to gender. Skewed distributed parameters were presented as medians with interquartile ranges and comparisons were analyzed by the Mann-Whitney U test. Categorical variables were compared between groups by chi-squared analysis. If 1of the cell expected counts has value less than 10, we used Fisher's exact test instead of chi-squared test to obtain P values for categorical variables. Receiver-operating characteristic (ROC) curve analysis was used to determine the optimum cut-off points of age and admission serum Cr concentration best predicting adverse outcome in this group. Hazard ratios (HR) and 95% confidence intervals (CI) for all-cause mortality were calculated using a Cox proportional hazards regression model. Differences were considered to be significant if the null hypothesis could be rejected with >95% confidence. All p-values are two-tailed. To analyze possible positive or negative interactions between admission Cr levels and age or sex, 4×2 table approach was used to calculate Hazard ratios (HR), respective 95% confidence intervals (CI) and two-tailed p values, as well as synergy measures in additive (SI) and multiplicative models (SIM). It was assumed that unexposed individuals without the risk creatinine level have a certain background risk for all-cause mortality (HR00 is assumed to be 1); HR10 refers to the relative risk for all-cause mortality among people without the risk creatinine level but exposed to the environmental risk factor (old age or female gender)relative to those with neither the risk creatinine level nor exposure; HR01 refers to the relative risk among people with the risk creatinine level who are not exposed to the risk factors relative to those with neither the risk creatinine level nor exposure; HR11 is the ratio of all-cause mortality risk among exposed people with risk creatinine level relative to unexposed people without the renal dysfunction. These HRs were then used in the calculation of synergy indexes: SI = (HR11-1)/(HR10+HR01-2), SIM = HR11/(HR10×HR01); the relative excess risk due to interaction, RERI = HR11-HR10-HR01+1;and the attributable proportion of the disease due to interaction, AP = RERI/HR11 [12], [13]. We then divided patients into three groups on the basis of age: <60 years old, 60∼74 years old, ≥75 years old. Odds ratios and 95% CIs were calculated for patients with elevated Cr level compared with patients with normal Cr level in each age group to examine the combined impact of age and serum Cr level on in-hospital mortality.

Results

Clinical characteristics of study population

The clinical characteristics of patients are shown in . A total of 1424 patients (1128 males and 296 females; median age, 65 years (range, 26–98 years)) were enrolled in the study. Female patients were older (p<0.001), less smoking and drinking (p<0.001), getting more diabetes (p = 0.007), having lower serum Cr level (p<0.001), getting less stent use (p<0.001) and having higher in-hospital mortality (p = 0.01), but no differences were found in the location of MI (p>0.05), history of hypertension (p = 0.32) and stroke (p = 0.38), EF of LV (p = 0.13) and Gensini score (p = 0.37) across two groups.
Table 1

Clinical characteristics of male and female patients with STEMI.

Male (n = 1128)Female (n = 296)P value
Age (years)61(52–71)67(60–74)<0.001
Smoking (%)621(55.1%)18(6.08%)<0.001
Drinking (%)272(24.1%)4(1.35%)<0.001
Hypertension (%)619(54.8%)172(58.1%)0.32
Diabetes (%)251(13.4%)88(51.2%)0.007
Stroke (%)50(4.43%)16(5.40%)0.38
Location of MI
Anterior (%)332(29.4%)98(33.1%)0.22
Inferior (%)454(40.2%)111(37.5%)0.39
Lateral (%)39(3.45%)9(3.04%)0.72
CK level (U/L)346(87.9–1673)202(64.3–817)<0.001
Cr level (µmol/L)79.0(67.9–91.45)63.5(56.0–74.6)<0.001
EF of LV (%)61.8(56.0–65.3)62.9(58.5–66.4)0.13
Gensini score53.0(30.5–83.0)50.0(31.0–80.5)0.37
Stent use (%)759(67.3%)149(50.3%)<0.001
Mortality (%)56(4.96%)26(8.78%)0.01

CK: Creatinine kinase; Cr: Creatinine; EF of LV: Ejection fraction of left ventricular.

CK: Creatinine kinase; Cr: Creatinine; EF of LV: Ejection fraction of left ventricular.

Results of ROC curve analysis and cox proportional hazards analysis

Receiver operating characteristic (ROC) analysis was applied to demonstrate cut-off points of serum creatinine 99.30 µmol/l and 73 year-old best predicting in-hospital mortality respectively. So, the normal serum creatinine group (normal group) was defined as <99.30 µmol/l, and the elevated serum creatinine group (elevated group) was defined as ≥99.30 µmol/l. while the young group <73 years old and the old group ≥73 years old. The results of ROC curve analysis were showed in and .Univariate Cox proportional hazards regression model showed old age (HR 1.69, 95%CI 1.40∼2.04), female gender (HR 1.69, 95%CI 1.05∼2.71), and renal dysfunction (HR 5.92, 95%CI 3.78∼9.28) were all associated with a higher in-hospital mortality. After adjusting for other confounders, including smoking and drinking status, diabetes, CK levels and stent use, the renal dysfunction was still strongly associated with a higher risk of death (HR 2.48, 95% CI 1.32∼4.63), while female gender(HR 1.19,95%CI 0.62∼2.29) and old age (HR 1.77, 95%CI 0.92∼3.37) not ( ).
Table 2

Receive operating characteristic analysis of age(years) and admission serum creatinine level (µmol/l) in predicting all-cause mortality.

Variable Cut-off Sensitivity Specificity AUC 95%CI P
Age(years)730.570.770.69(0.63∼0.75)<0.001
Creatinine(µmol/l)99.300.600.820.73(0.66∼0.79)<0.001

AUC: Area under the curve; 95%CI: 95% confidence interval.

Figure 1

Receive operating characteristic analysis of age(years) and admission serum Cr level(µmol/l) in predicting all-cause mortality.

Table 3

Cox proportional hazards regression analysis of the effect of risk factors on in-hospital mortality.

Variable B SE Wald hazard ratios (95% CI) P value Adjusted HRs(95%CI)
Age(old/young)1.200.2328.03.33(2.13–5.20)<0.0011.77(0.92–3.37)
Gender (female/male)0.520.244.691.69(1.05–2.71)0.031.19(0.62–2.29)
Creatinine (elevated/normal)1.780.2360.35.92(3.78–9.22)<0.0012.48(1.32–4.63)
AUC: Area under the curve; 95%CI: 95% confidence interval.

Interaction between Cr level and age or sex

The analysis of the possible positive/negative association between renal dysfunction and old age or female gender is expressed in and . Regarding the conventional risks of the male or young with normal Cr level (reference category) as being 1.0, the HRs estimating the effects of joint exposure to elevated Cr level and female gender or old age were significantly higher than the HRs estimating the effects of each factor in the absence of the other. The risk provided by renal dysfunction was found to be positively reinforced by the female gender (SI = 3.01, SIM = 2.10, AP = 0.55) for in-hospital morality in the acute STEMI patients. Since the synergy index in multiplicative model (SIM) for renal dysfunction and old age was less than 1 (SI = 1.34, SIM = 0.57, AP = 0.14), we then performed a stratified analysis. Patients were divided into three groups stated above. As expected, the old patients had higher mortality. But, the adjusted risk of in-hospital mortality for patients with renal insufficiency compared with those with normal renal function was higher in young patients (odds ratio 11.10, 95% CI 3.72 to 33.14) than middle-aged patients (odds ratio 5.18, 95% CI 2.48∼10.83) and old patients (odds ratio 3.99, 95% CI 1.89 to 8.42) ( and ).
Table 4

Combined effect of admission serum Creatinine level and age in predicting all-cause mortality.

Risk Age Risk Creatinine Death Alive HR(95%CI)
00188731
01171246.33(3.23–12.4)
10152312.96(1.48–5.94)
113211410.8(5.95–19.5)

SI = 1.34;SIM = 0.57;RERI = 1.49;AP = 0.14.

Zero refers to the young or normal Cr group while one the old or elevated group.

Table 5

Combined effect of admission serum Creatinine level and gender in predicting all-cause mortality.

Risk Gender Risk Creatinine Death Alive HR(95%CI)
00238681
01332044.99(2.92–8.56)
10102361.34(0.62–2.89)
11163414.0(7.41–26.6)

SI = 3.01;SIM = 2.10;RERI = 7.71;AP = 0.55.

Zero refers to the male or normal Cr group while one the female or elevated group.

Table 6

Unadjusted mortalities of each age group across different serum Cr level.

Creatinine levels(µmol/L)Age groups(years)P value
<60(n = 522)60∼74(n = 599)≥75(n = 303)
Normal Cr level1.5%(7/473)3.1%(15/486)6.2%(11/178)0.01
Elevated Cr level14.3%(7/49)14.2%(16/113)20.8%(26/125)0.34
Figure 2

Odds ratios and 95% CIs of in-hospital mortality in 3 age groups: young (<60 years old), middle-aged (60∼74 years old) and elderly (≥75years old) according to admission serum Cr level compared with patients with normal renal function.

p<0.01 by Cochran's and Mantel-Haenszel tests.

Odds ratios and 95% CIs of in-hospital mortality in 3 age groups: young (<60 years old), middle-aged (60∼74 years old) and elderly (≥75years old) according to admission serum Cr level compared with patients with normal renal function.

p<0.01 by Cochran's and Mantel-Haenszel tests. SI = 1.34;SIM = 0.57;RERI = 1.49;AP = 0.14. Zero refers to the young or normal Cr group while one the old or elevated group. SI = 3.01;SIM = 2.10;RERI = 7.71;AP = 0.55. Zero refers to the male or normal Cr group while one the female or elevated group.

Discussion

In this study, we showed that admission serum Cr level was a strong predictor for in-hospital mortality among acute STEMI patients in China and had combined impacts with age and gender. As early as in 1998, Herzog et al. had unveiled that patients with end-stage renal disease suffering acute MI faced the horrible prognosis [16].Recently, In Yamaguchi J et al.'s study, the mortality of in-hospital and long-term in patients with AMI, even undergoing successful primary PCI, was greater when serum Cr level was elevated even slightly [17], [18]. The concept of renal dysfunction as a potent risk factor for the adverse outcomes in patients with cardiovascular disease has attracted a great deal of attention. There are multiple possible explanations for the association of higher mortality and elevated serum Cr level, such as serum creatinine was a marker of specific vascular disease, chronic overload, endothelial dysfunction, impaired myocardial blood flow [7], [19], [20]. It has been reported that hypoperfusion after the acute STEMI, nephrotoxicity of contrast medium used for primary PCI and other cardiovascular drugs could induce the renal dysfunction [11], [21]. And the renal dysfunction is associated with adverse LV remodeling indicating combined cardiac and renal dysfunction (called “cardio-renal syndrome”), which synergistically accelerates the progression of startling morbidity and mortality [21], [22]. In addition, Clinical studies have greatly expanded efforts to recognize the importance of gender and age in the prognosis of acute STEMI patients [9], [13], [23], [24], revealing female gender and old age as predictors of adverse outcomes in patients with acute STEMI. The higher mortality for the old is not surprising given the high prevalence of risk factors and graver heart condition in these patients. In our research, after adjusting for related confounders described above, old age was no more a significant predictor for in-hospital mortality in acute STEMI patients. Previous studies has clarified that advanced age is associated with narrowing and blunted vasodilatory capacity of renal vessels inducing reduced renal perfusion and impairing renal function, which lead to adverse LV remodeling stated above [11],[22]. Though mortality was higher in the old, the Odds ratio and 95%CI were greater in the young, meaning that the impact of worsening renal function appears to be greater in young patients compared with middle-aged and old patients. Similar paradox was found in Cardarelli F et al.'s observation [25]. Cr level of the female was relatively lower compared with men (female patients (median age, 70) much older than the male patients (median age, 63)) in this study (p<0.001). This may partially attribute to the lower muscle mass of women. Thus, the same Cr level may indicate worse renal damage in female patients. Also, a higher prevalence of chronic renal insufficiency (CRI) had been confirmed in DM2 patients [26], and women with diabetes have more than a 40% greater risk of incident coronary heart disease compared with men with diabetes [27]. So, we consider the higher prevalence of diabetes in female patients also may account for the synergistic effect of renal dysfunction and female gender on in-hospital mortality in this study. Other age-related risk factors and co-morbid conditions could be associated with the high in-hospital mortality in female patients as well [13]. Similarly, the higher mortality of female patients may due to the older age, more diabetes and less stent use in our research. Our data showed synergistic effect of renal dysfunction and female gender on in-hospital mortality in patients with acute STEMI. The mechanism of the phenomenon needs more studies. These observations unveil the horrible prognosis faced by acute STEMI patients with elevated admission serum Cr concentration, especially by the young and female patients, calling for targeted strategies to reduce the burden of risk in this population. And future clinical trials studying therapies for coronary artery disease need to be more inclusive of patients with renal insufficiency [28].

Limitations

There were also a few limitations to our study. First, the study was single-centered and the number of the cases was limited. Second, using serum creatinine concentration to measure the renal function may underestimate its risk on the basis that it has been clarified that glomerular filtration rate estimates renal function more precisely [25].

Conclusions

In this study, we showed that serum Cr concentration on admission was a strong predictor for in-hospital mortality in patients with acute STEMI in China in association with age and gender.
  27 in total

1.  Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater Paris area PCI Registry.

Authors:  Hakim Benamer; Muriel Tafflet; Sophie Bataille; Sylvie Escolano; Bernard Livarek; Vincent Fourchard; Christophe Caussin; Emmanuel Teiger; Philippe Garot; Yves Lambert; Xavier Jouven; Christian Spaulding
Journal:  EuroIntervention       Date:  2011-04       Impact factor: 6.534

2.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

Review 3.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

4.  Age may contribute to the negative cardiac effect of postconditioning on STEMI patients.

Authors:  Chenghui Zhou; Lihuan Li
Journal:  Int J Cardiol       Date:  2012-10-17       Impact factor: 4.164

5.  Population trends in the incidence and outcomes of acute myocardial infarction.

Authors:  Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go
Journal:  N Engl J Med       Date:  2010-06-10       Impact factor: 91.245

6.  Influence of age on long-term outcome after emergent percutaneous coronary intervention for ST-elevation myocardial infarction.

Authors:  Chin Hiew; Trent Williams; Rachael Hatton; Seshasayee Narasimhan; Simon O'Connor; Fran Baker; Patrick McElduff; John Attia; Nicholas Collins
Journal:  J Invasive Cardiol       Date:  2010-06       Impact factor: 2.022

7.  Outline of the report on cardiovascular disease in China, 2010.

Authors:  Sheng Shou Hu; Ling Zhi Kong; Run Lin Gao; Man Lu Zhu; Wen Wang; Yong Jun Wang; Zhao Su Wu; Wei Wei Chen; Ming Bo Liu
Journal:  Biomed Environ Sci       Date:  2012-06       Impact factor: 3.118

8.  Gender disparity in early death after ST-elevation myocardial infarction.

Authors:  Bo Zhang; Wei Zhang; Rong-Chong Huang; Yan Zhang; Jun Liu; Zheng-Guo Zheng; Da-Ming Jiang; Yu-Jiao Sun; Li-Na Ren; Xu-Chen Zhou; Guo-Xian Qi
Journal:  Chin Med J (Engl)       Date:  2013       Impact factor: 2.628

9.  The China Patient-Centered Evaluative Assessment of Cardiac Events (China PEACE) retrospective study of acute myocardial infarction: study design.

Authors:  Kumar Dharmarajan; Jing Li; Xi Li; Zhenqiu Lin; Harlan M Krumholz; Lixin Jiang
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-11-12

10.  [Prevalence of chronic renal insufficiency in diabetic type 2 diabetes patients based on the estimated glomerular filtration rate and relation with cardiovascular risk].

Authors:  Teresa Mur Martí; Mercè Villaró Gabarrós; Nuria Porta Martínez; Angels Jaén Manzanera
Journal:  Med Clin (Barc)       Date:  2012-05-08       Impact factor: 1.725

View more
  3 in total

1.  Predictive modeling of inpatient mortality in departments of internal medicine.

Authors:  Naama Schwartz; Ali Sakhnini; Naiel Bisharat
Journal:  Intern Emerg Med       Date:  2017-12-30       Impact factor: 3.397

2.  Effectiveness and safety of recombinant human brain natriuretic peptide in the treatment of acute myocardial infarction in elderly in combination with cardiac failure.

Authors:  Hong Xu; Bosong Wang; Qingmei Meng; Jinlong Li; Weidong Sun; Li Xin; Liping Chen
Journal:  Pak J Med Sci       Date:  2017 May-Jun       Impact factor: 1.088

3.  Gender Differences among Elderly Patients with Primary Percutaneous Coronary Intervention.

Authors:  Binquan You; Bingbing Zhu; Xi Su; Feng Liu; Bingyin Wang
Journal:  Aging Dis       Date:  2018-10-01       Impact factor: 6.745

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.